[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Insulin Market Size, Share & Trends Analysis By Product Type (Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin, Biosimilar), By Application, By Type (Type 1, Type 2), By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030

July 2022 | 150 pages | ID: I184545F0492EN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 3 Business Days

Insulin Market Growth & Trends

The global insulin market is expected to reach USD 23.20 billion by 2030, expanding at a CAGR of 1.5% during the forecast period, according to a new report by Grand View Research, Inc. It is an oligopolistic space dominated by companies such as Novo Nordisk A/S, Sanofi, and Eli Lilly and Company. The increasing incidence of diabetes and formulation advancements in insulin delivery are the primary factors driving growth. However, the presence of biosimilars and drugs such as GLP-1 RAs for the treatment of type 2 diabetes can slow down market growth to a certain extent.

Diabetes is one of the fastest-growing chronic diseases in the world. Its prevalence has increased steadily over the past few decades. The prevalence of the disease is growing rapidly in low- and middle-income countries; three in four adults live with diabetes in these countries. According to the International Diabetes Federation (IDF) data from 2021, approximately 643 million individuals will have diabetes by 2030 and 783 million by 2045. In addition, the increase in geriatric and obese populations is another factor driving growth. The overweight population is at risk of developing type 2 diabetes mellitus. According to WHO, in 2020, 1.9 billion adults were found to be overweight, accounting for 39% of the population within that age group.

Formulation advancements in insulin delivery systems are being developed, the release of which is likely to propel the market over the forecast period. In December 2019, Tandem Diabetes Care’s Control-IQ, an interoperable device, received FDA authorization for marketing in the U.S. It is an automated insulin dosing algorithm that can be used with other interoperable devices.

The top three manufacturing companies, Eli Lilly and Company, Novo Nordisk A/S, and Sanofi, hold a monopoly. These companies hold more than 90% of the market share. Owing to the oligopolistic nature of the market and patent protection, the cost of insulin is high. Hence, the high cost of products could impede industry growth.

The COVID-19 pandemic caused a detrimental impact on the industry. Individuals with chronic illnesses, such as diabetes, have experienced substantial disruptions in emergency and routine medical care. According to an NCBI article, out of ~30 million diabetic patients in America, about 7.5 million are dependent on insulin. Insulin rationing or hoarding has already been a rampant issue, which increased further amid the pandemic due to supply concerns. However, in several countries, the effect of COVID-19 declined to post the third quarter of 2020, which helped the market regain traction.

Insulin Market Report Highlights
  • The long-acting insulin segment contributed a significant revenue share of 56.53% in 2021. Factors such as patent protection and high demand due to long-term effects are expected to drive the segment
  • Type 1 diabetes mellitus is the largest segment by application in 2021 due to the high insulin dependency of these patients
  • Insulin analog segment dominated in 2021. It is due to the higher efficacy of insulin and minimal adverse effects, such as hypoglycemic attacks and lower weight gain, as compared to conventional therapy
  • The retail pharmacy segment dominated the distribution channel in 2021 due to the presence of retail pharmacy chains and tie-ups of these chains with hospitals
  • North America dominated the market in terms of revenue in 2021, mainly due to the dominance of branded products and the increasing prevalence of diabetes in the region
CHAPTER 1 METHODOLOGY AND SCOPE

1.1 Market segmentation
  1.1.1 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
  1.3.1 Purchased database
  1.3.2 GVR’S internal database
  1.3.3 Secondary sources
  1.3.4 Primary research
  1.3.5 Details of primary research
  1.3.6 List of primary sources
1.4 Information or data analysis
  1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
  1.6.1 Commodity flow analysis
    1.6.1.1 Approach 1: Commodity Flow Approach
    1.6.1.2 Approach 2: Country-wise market estimation using the bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Abbreviations
1.11 Objectives
  1.11.1 Objective
  1.11.2 Objective
  1.11.3 Objective
  1.11.4 Objective

CHAPTER 2 EXECUTIVE SUMMARY

2.1 Market Summary

CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE

3.1 Market Lineage Outlook
  3.1.1 Parent market outlook
3.2 Regulatory framework
3.3 Penetration and Growth Prospect Mapping
3.4 Pipeline Analysis
3.5 Market Dynamics
  3.5.1 Market driver analysis
    3.5.1.1 Increase in prevalence of diabetes
    3.5.1.2 Increase in geriatric and obese population
    3.5.1.3 Formulation advancements in insulin delivery systems
  3.5.2 Market restraint analysis
    3.5.2.1 High cost of insulin
    3.5.2.2 Poor reimbursement policies
    3.5.2.3 Launch of insulin biosimilars and increasing penetration of glp-1 agonists
3.6 Porter's Five Forces Analysis
3.7 PESTEL Analysis
3.8 COVID-19 Impact

CHAPTER 4 GLOBAL INSULIN MARKET - SEGMENT ANALYSIS, BY PRODUCT TYPE, 2018 - 2030 (USD MILLION)

4.1 Global Insulin Market: Product Type Movement Analysis
4.2 Rapid-Acting Insulin
  4.2.1 Rapid-acting insulin market estimates and forecast, 2018 - 2030 (USD Million)
4.3 Long-acting Insulin
  4.3.1 Long-acting insulin market estimates and forecast, 2018 - 2030 (USD Million)
4.4 Combination Insulin
  4.4.1 Combination insulin market estimates and forecast, 2018 - 2030 (USD Million)
4.5 Biosimilar
  4.5.1 Biosimilar market estimates and forecast, 2018 - 2030 (USD Million)
4.6 Others
  4.6.1 Other market estimates and forecast, 2018 - 2030 (USD Million)

CHAPTER 5 GLOBAL INSULIN MARKET - SEGMENT ANALYSIS, BY TYPE, 2018 - 2030 (USD MILLION)

5.1 Global Insulin Market: Type Movement Analysis
5.2 Human Insulin
  5.2.1 Human Insulin Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3 Insulin Analog
  5.3.1 Insulin Market Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 6 GLOBAL INSULIN MARKET - SEGMENT ANALYSIS, APPLICATION, 2018 - 2030 (USD MILLION)

6.1 Global Insulin Market: Application Movement Analysis
6.2 Type 1 Diabetes Mellitus
  6.2.1 Type 1 diabetes mellitus market estimates and forecast, 2018 - 2030 (USD Million)
6.3 Type 2 Diabetes Mellitus
  6.3.1 Type 2 diabetes mellitus market estimates and forecast, 2018 - 2030 (USD Million)

CHAPTER 7 GLOBAL INSULIN MARKET - SEGMENT ANALYSIS, BY DISTRIBUTION CHANNEL, 2018 - 2030 (USD MILLION)

7.1 Global Insulin Market: Distribution Channel Movement Analysis
7.2 Hospital Pharmacy
  7.2.1 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
7.3 Retail Pharmacy
  7.3.1 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
7.4 Others
  7.4.1 Other market estimates and forecast, 2018 - 2030 (USD Million)

CHAPTER 8 INSULIN MARKET: SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)

8.1 Insulin Market: Regional Movement Analysis
  8.1.1 North America
    8.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
    8.1.1.2 U.S.
      8.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    8.1.1.3 Canada
      8.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  8.1.2 Europe
    8.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
    8.1.2.2 UK
      8.1.2.2.1 UK market estimates and forecast, 2018 - 2030 (USD Million)
    8.1.2.3 Germany
      8.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
    8.1.2.4 France
      8.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
    8.1.2.5 Spain
      8.1.2.5.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
    8.1.2.6 Italy
      8.1.2.6.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  8.1.3 Asia Pacific
    8.1.3.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
    8.1.3.2 Japan
      8.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
    8.1.3.3 China
      8.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
    8.1.3.4 India
      8.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Million)
    8.1.3.5 Australia
      8.1.3.5.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
    8.1.3.5 South Korea
      8.1.3.5.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  8.1.4 Latin America
    8.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
    8.1.4.2 Brazil
      8.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    8.1.4.3 Mexico
      8.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    8.1.4.4 Argentina
      8.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  8.1.5 Middle East & Africa
    8.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
    8.1.5.2 South Africa
      8.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    8.1.5.3 Saudi Arabia
      8.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    8.1.5.5 United Arab Emirates
      8.1.5.5.1 United Arab Emirates market estimates and forecast, 2018 - 2030 (USD Million)

CHAPTER 9 GLOBAL INSULIN MARKET: COMPETITIVE ANALYSIS

9.1 Recent Developments and Impact Analysis, by Key Market Participants
  9.1.1 Synergy analysis: major deals and strategic alliances
    9.1.1.1 New Product Launches
    9.1.1.2 Mergers and Acquisitions
    9.1.1.3 Partnerships & Agreements
9.2 Company Categorization
  9.2.1 Innovators
  9.2.2 Market Leaders
  9.2.3 Emerging Players
  9.2.4 Heat Map Analysis
9.3 Company Market Position Analysis
9.4 Vendor Landscape
  9.4.1 List of Key Distributors and Channel Partners
  9.4.2 List of Potential End-Users
  9.4.3 Key Company Market Share Analysis, 2021
9.5 Company Market Share/Ranking, 2021
  9.5.1 Company Market Share/Ranking, Rapid-Acting Insulin, 2021
  9.5.2 Company Market Share/Ranking, Long-Acting Insulin, 2021
  9.5.3 Company Market Share/Ranking, Biosimilars, 2021
  9.5.4 Company Market Share/Ranking, Others, 2021
  9.5.5 Competitive Dashboard Analysis
9.6 Private Companies
  9.6.1 List of Key Emerging Companies
  9.6.2 Regional Network Map
9.7 Company Profiles
  9.7.1 Eli Lilly and Company
    9.7.1.1 Company overview
    9.7.1.2 Financial performance
    9.7.1.3 Product benchmarking
    9.7.1.4 Strategic initiatives
  9.7.2 Sanofi
    9.7.2.1 Company overview
    9.7.2.2 Financial performance
    9.7.2.3 Product benchmarking
    9.7.2.4 Strategic initiatives
  9.7.3 Novo Nordisk A/S
    9.7.3.1 Company overview
    9.7.3.2 Financial performance
    9.7.3.3 Product benchmarking
    9.7.3.4 Strategic initiatives
  9.7.4 Biocon
    9.7.4.1 Company overview
    9.7.4.2 Financial performance
    9.7.4.3 Product benchmarking
    9.7.4.4 Strategic initiatives
  9.7.5 Boehringer Ingelheim International GmbH
    9.7.5.1 Company overview
    9.7.5.2 Financial performance
    9.7.5.3 Product benchmarking
    9.7.5.4 Strategic initiatives
  9.7.6 Tonghua Dongbao Pharmaceutical Co. Ltd.
    9.7.6.1 Company overview
    9.7.6.2 Product benchmarking
    9.7.6.3 Strategic initiatives
  9.7.7 Wockhardt
    9.7.7.1 Company overview
    9.7.7.2 Financial performance
    9.7.7.3 Product benchmarking
  9.7.8 Julphar
    9.7.8.1 Company overview
    9.7.8.2 Financial performance
    9.7.8.3 Product benchmarking
    9.7.8.4 Strategic initiatives
  9.7.9 The United Laboratories International Holdings Limited
    9.7.9.1 Company overview
    9.7.9.2 Financial performance
    9.7.9.3 Product benchmarking
LIST OF TABLES

Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 North America insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 4 North America insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 5 North America insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 6 North America insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 7 U.S. insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 8 U.S. insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 9 U.S. insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 10 U.S. insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 11 Canada insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 12 Canada insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 13 Canada insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 14 Canada insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 15 Europe insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 16 Europe insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 17 Europe insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 18 Europe insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 19 UK insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 20 UK insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 21 UK insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 22 UK insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 23 Germany insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 24 Germany insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 25 Germany insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 26 Germany insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 27 France insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 28 France insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 29 France insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 30 France insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 31 Italy insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 32 Italy insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 33 Italy insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 34 Italy insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 35 Spain insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 36 Spain insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 37 Spain insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 38 Spain insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 39 Asia Pacific insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 40 Asia Pacific insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 41 Asia Pacific insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 42 Asia Pacific insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 43 Japan insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 44 Japan insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 45 Japan insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 46 Japan insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 47 China insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 48 China insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 49 China insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 50 China insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 51 India insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 52 India insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 53 India insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 54 India insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 55 Australia insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 56 Australia insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 57 Australia insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 58 Australia insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 59 South Korea insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 60 South Korea insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 61 South Korea insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 62 South Korea insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 63 Latin America insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 64 Latin America insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 65 Latin America insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 66 Latin America insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 67 Brazil insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 68 Brazil insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 69 Brazil insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 70 Brazil insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 71 Mexico insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 72 Mexico insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 73 Mexico insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 74 Mexico insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 75 Argentina insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 76 Argentina insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 77 Argentina insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 78 Argentina insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 79 MEA insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 80 MEA insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 81 MEA insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 82 MEA insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 8 South Africa insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 82 South Africa insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 83 South Africa insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 84 South Africa insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 90 UAE insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 91 UAE insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 92 UAE insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 93 UAE insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 94 List of key distributors
LIST OF FIGURES

Fig. 1 Global Insulin market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity flow analysis
Fig. 10 Global insulin market snapshot, 2021
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Global insulin market driver impact
Fig. 13 Global diabetes prevalence data and forecast (Numbers in millions)
Fig. 14 Global Insulin Market Restraint Impact
Fig. 15 Sources of healthcare financing according to country income, 2020 (%)
Fig. 16 Porter's five forces analysis
Fig. 17 Global insulin market: Product type outlook and key takeaways
Fig. 18 Global insulin market: Product type movement analysis
Fig. 19 Rapid-acting insulin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Long-acting insulin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Combination Insulin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Biosimilar market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Other market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Global insulin market: type outlook and key takeaways
Fig. 25 Global insulin market: Type movement analysis
Fig. 26 Human insulin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Insulin analog market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Global insulin market: Application type outlook and key takeaways
Fig. 29 Global insulin market: Application type movement analysis
Fig. 30 Type 1 diabetes mellitus market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Type 2 diabetes mellitus market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Global insulin market: Distribution channel outlook and key takeaways
Fig. 33 Global insulin market: Distribution channel movement analysis
Fig. 34 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Regional marketplace: Key takeaways
Fig. 39 Regional outlook, 2018 & 2030
Fig. 40 North America insulin market, 2018 - 2030 (USD Million)
Fig. 41 U.S. insulin market, 2018 - 2030 (USD Million)
Fig. 42 Canada insulin market, 2018 - 2030 (USD Million)
Fig. 43 Europe insulin market, 2018 - 2030 (USD Million)
Fig. 44 UK. insulin market, 2018 - 2030 (USD Million)
Fig. 45 Germany insulin market, 2018 - 2030 (USD Million)
Fig. 46 Italy insulin market, 2018 - 2030 (USD Million)
Fig. 47 Spain insulin market, 2018 - 2030 (USD Million)
Fig. 48 France insulin market, 2018 - 2030 (USD Million)
Fig. 49 Asia Pacific insulin market, 2018 - 2030 (USD Million)
Fig. 50 Japan insulin market, 2018 - 2030 (USD Million)
Fig. 52 India insulin market, 2018 - 2030 (USD Million)
Fig. 53 Australia insulin market, 2018 - 2030 (USD Million)
Fig. 54 South Korea insulin market, 2018 - 2030 (USD Million)
Fig. 55 Latin America insulin market, 2018 - 2030 (USD Million)
Fig. 56 Brazil insulin market, 2018 - 2030 (USD Million)
Fig. 57 Mexico insulin market, 2018 - 2030 (USD Million)
Fig. 58 Argentina insulin market, 2018 - 2030 (USD Million)
Fig. 59 MEA insulin market, 2018 - 2030 (USD Million)
Fig. 60 South Africa insulin market, 2018 - 2030 (USD Million)
Fig. 61 Saudi Arabia insulin market, 2018 - 2030 (USD Million)
Fig. 62 UAE insulin market, 2018 - 2030 (USD Million)
Fig. 63 Heat map analysis
Fig. 64 Company market position analysis, 2021
Fig. 65 Company market position analysis, 2021
Fig. 66 Company market share analysis (2021)
Fig. 67 Market differentiators


More Publications